- Open Access
Diagnostic value of transpulmonary thermodilution measurements for acute respiratory distress syndrome in a pig model of septic shock
Journal of Translational Medicine volume 20, Article number: 617 (2022)
No direct approach assessing pulmonary vascular permeability exists in the current therapeutic strategy for patients with acute respiratory distress syndrome (ARDS). Transpulmonary thermodilution measures hemodynamic parameters such as pulmonary vascular permeability index and extravascular lung water, enabling clinicians to assess ARDS severity. The aim of this study is to explore a precise transpulmonary thermodilution-based criteria for quantifying the severity of lung injury using a clinically relevant septic-ARDS pig model.
Thirteen female pigs (weight: 31 ± 2 kg) were intubated, mechanically ventilated under anesthesia, and either assigned to septic shock-induced ARDS or control group. To confirm the development of ARDS, we performed computed tomography (CT) imaging in randomly selected animals. The pulmonary vascular permeability index, extravascular lung water, and other hemodynamic parameters were consecutively measured during the development of septic lung injury. Lung status was categorized as normal (partial pressure of oxygen/fraction of inspired oxygen ≥ 400), or injured at different degrees: pre-ARDS (300–400), mild-to-moderate ARDS (100–300), or severe ARDS (< 100). We also measured serum inflammatory cytokines and high mobility group box 1 levels during the experiment to explore the relationship of the pulmonary vascular permeability index with these inflammatory markers.
Using CT image, we verified that animals subjected to ARDS presented an extent of consolidation in bilateral gravitationally dependent gradient that expands over time, with diffuse ground-glass opacification. Further, the post-mortem histopathological analysis for lung tissue identified the key features of diffuse alveolar damage in all animals subjected to ARDS. Both pulmonary vascular permeability index and extravascular lung water increased significantly, according to disease severity. Receiver operating characteristic analysis demonstrated that a cut-off value of 3.9 for the permeability index provided optimal sensitivity and specificity for predicting severe ARDS (area under the curve: 0.99, 95% confidence interval, 0.98–1.00; sensitivity = 100%, and specificity = 92.5%). The pulmonary vascular permeability index was superior in its diagnostic value than extravascular lung water. Furthermore, the pulmonary vascular permeability index was significantly associated with multiple parameters reflecting clinicopathological changes in animals with ARDS.
The pulmonary vascular permeability index is an effective indicator to measure septic ARDS severity.
Acute respiratory distress syndrome (ARDS) is a life-threatening condition characterized by non-cardiogenic pulmonary edema and rapid progressive diffuse alveolar damage (DAD) . Despite progress in lung protective strategies, ARDS is associated with high mortality, which ranges from 35–46% among patients . There is no effective pharmacotherapy to supplement lung protective ventilation management for improving patient outcomes in ARDS. This can be attributed to the absence of a precise definition of ARDS [3, 4]. Unfortunately, the current “Berlin definition” is not useful for assessing lung severity [5, 6], thereby increasing the difficulties in the management of patients with ARDS. Of note, among all patients who met the Berlin definition of ARDS, only 45% had DAD . Therefore, the development of direct and highly reproducible approaches for assessing pulmonary vascular permeability and extravascular lung water (EVLW) is an unmet medical need.
Optimal fluid management is crucial in critically ill patients [8,9,10]. Transpulmonary thermodilution (TPTD) is an established technique for comprehensively measuring the hemodynamic parameters, extravascular lung volume, and lung permeability at the bedside [8, 11,12,13]. A body of evidence have shown the clinical usefulness of the TPTD technique for quantitative measurement of EVLW and pulmonary vascular permeability in previous decades [14,15,16,17,18,19,20]. The normal range of the EVLW indexed to the actual body weight (i.e., extravascular lung water index: ELWI) is < 10 mL/kg, according to early human observational studies [14, 15]. Higher pulmonary vascular permeability is another hallmark of ARDS and can be assessed by calculating the pulmonary vascular permeability index (PVPI), which refers to the ratio between the ELWI and pulmonary blood volume [11, 14, 18, 21]. PVPI obtained using a TPTD is the only procedure to estimate the degree of lung permeability at the bedside. Currently, a PVPI value > 3 (concurrent with ELWI > 10 mL/kg) is widely used in clinical settings as the threshold suggestive of permeability pulmonary edema or ARDS . This threshold has been based on early human observational studies [14, 17, 18]. However, the PVPI is calculated from the ELWI and pulmonary blood volume. Distributive shock and/or severe cardiac dysfunction would affect the threshold in terms of ARDS diagnosis during septic shock. Nevertheless, no animal or human studies has investigated the PVPI threshold for detecting ARDS during septic shock.
Herein, we intended to demonstrate a highly reproducible pig model of sepsis-induced ARDS with hypodynamic shock, induced by “two hits” of lipopolysaccharide (LPS) injections under mechanical ventilation with 100% oxygen. We aimed to explore a precise TPTD-based criteria for quantifying the severity of lung injury using this clinically relevant septic-ARDS model. We hypothesized that PVPI can be a feasible and useful indicator to detect the severity of ARDS during septic shock.
This study was approved by the ethics committee for animal experiments at the Rakuno Gakuen University (Protocol Number, VH19B14). The care and handling of the animals were performed in accordance with the guidelines of the National Institutes of Health.
We used thirteen healthy LWD pigs (aged 3–4 weeks, weight 29–34 kg). Animals were premedicated with an intramuscular injection of medetomidine hydrochloride (40.0 µg/kg), midazolam (0.2 mg/kg), and butorphanol tartrate (0.2 mg/kg). They underwent tracheal intubation following anesthesia using propofol (6 mg/kg). We maintained general anesthesia with 2% sevoflurane (Sevoflo®, Dainippon-Sumitomo Pharma, Osaka, Japan) during the experiment. Neuromuscular blockade was achieved by vecuronium (2 mg/kg, Musculate®, Fuji Pharma Co., Tokyo, Japan) and maintained by its continuous infusion (0.1 mg/kg/h) throughout the experiment. All animals were mechanically ventilated in the volume-control mode (10 mL/kg, Flow-i, Maquet, Sonia, Sweden). The right femoral artery was catheterized with a thermistor-tipped 4 Fr Pulse index Continuous Cardiac Output (PiCCO) catheter (PV2014L16, Pulsion Medical Systems AG, Munich, Germany) connected to a Pulsioflex (Getinge, Göteborg, Sweden). We inserted a 6 Fr double-lumen central venous catheter (UK catheter kit UB-0610-W, 21G, 10 cm, Unitika Medical, Osaka, Japan) into the right jugular vein, positioned at the cranial end of the superior vena cava for injecting 0.9% of ice-cold saline. The distal ports of double lumen catheter were connected to the PiCCO2 sensor for the TPTD. All transducers were zeroed and positioned at the level of the right atrium.
We developed a novel model of septic shock and ARDS in which the animals were exposed to a “two-hit” LPS injection, thus exhibiting hypodynamic shock, hypoxia, systemic inflammation, and acute lung injury. The animals were mechanically ventilated with zero positive end-expiratory pressure (PEEP) and a fraction of inspired oxygen (FIO2) of 1.0 throughout the experiment. End-tidal carbon dioxide was maintained at 40 ± 5 mmHg during the experiment, by the adjustment of respiratory rate and tidal volume. Following hemodynamic stabilization for 30 min, septic-ARDS (n = 7) was induced by intravenous infusions of LPS, which was purified from Escherichia coli 055:B5 by ion-exchange chromatography (product number L4524, Sigma Aldrich, St Louis, MO, USA), beginning at 160 µg/kg/h and continued for 75 min. Subsequently, a second dose of LPS was infused as a “second hit” at 80 µg/kg/h, which continued until reaching a ratio of arterial partial oxygen pressure to fractional inspired oxygen (PaO2/FIO2 (P/F)) of < 300 mmHg (Fig. 1). The control group (n = 6) was equally subjected to two infusions of a similar volume of saline using the same infusion rate and timing as for the LPS infusion. TPTD measurements and arterial blood sampling were performed every 30 min. The survival rate was recorded for 4 h after the second dose of LPS. Subsequently, lung status was categorized as normal (P/F ≥ 400) or injured at different degrees: pre-ARDS (300 ≤ P/F < 400), mild-to-moderate ARDS (100 ≤ P/F < 300), or severe ARDS (P/F < 100).
In all animals, we measured the TPTD parameters using the PiCCO monitoring system . TPTD was precisely conducted as previously described . Briefly, (1) we used 10 mL of 0 °C physiological saline 0.9% as an indicator, (2) use of average of three times values, (3) the indicator was injected by the same operator (YE) throughout the experiment, (4) the indicator was injected for 2–3 s, (5) ΔT in TPTD (the change in blood temperature after indicator injection) was recorded; optimal = ΔT > 0.3, good = ΔT > 0.2, and bad = ΔT < 0.2, to verify the reliability of the measurement method. We recorded the stroke volume, cardiac output, mean arterial pressure (MAP), heart rate, systemic vascular resistance (SVR), global end-diastolic volume index (GEDI), stroke volume variation (SVV), pulse pressure variation (PPV), global ejection fraction, PVPI, and ELWI. ELWI was calculated from the absolute volume of EVLW divided by the actual body weight, whereas GEDV and CO are indexed using body surface area (BSA) calculated from body height and weight (GEDI and Cardiac Index, respectively) . The body surface area (BSA) of animal was calculated by the following equation: BSA (m2) = 0.0734 x body weight0.656 . Simultaneously, we monitored a perfusion index for the sepsis-induced ARDS model (Masimo SET Radical-7TM, Masimo, Irvine, CA, USA).
Blood gas analysis
Arterial blood sample was collected from the femoral artery at each measurement point to monitor PaO2, arterial carbon dioxide, and lactate levels (ABL-90 FLEX; Radiometer, Copenhagen, Denmark). We used the central venous blood gas for measuring the central venous oxygen saturation (ScvO2).
Measuring serum inflammatory cytokines and high mobility group box 1
Whole blood (0.5 mL) was collected from the arterial line into Microtainer® tubes (Becton Dickinson, Franklin Lakes, NJ, USA) with sera separator gel, and centrifuged at 3,000 g for 15 min to obtain the serum. The serum samples were stored at −80 ˚C until use. Simultaneously, we measured the serum concentrations of interleukin (IL)-1β, IL-4, IL-6, IL-8, IL-10, IL-12p40, interferon (IFN)-α, IFN-γ, and tumor necrosis factor (TNF)-α using the Bio-Plex Suspension Array System (Bio-Rad, Hercules, CA, USA) with the Porcine Cytokine & Chemokine 9-Plex ProcartaPlex™ Panel 1 (Invitrogen, Waltham, MA, USA), according to the manufacturer’s instruction. Furthermore, we measured serum high mobility group box 1 (HMGB1) concentrations by the HMGB1 ELISA Kit II (Shino-Test, Tokyo, Japan) according to the manufacturer’s instruction.
Computed tomography imaging
To confirm the development of ARDS, we performed computed tomography (CT) imaging in randomly selected two animals which were subjected to the LPS injections. Prior to the CT imaging, we specified the following criteria for ARDS: (1) impaired oxygenation (P/F < 300); (2) the severity of diffuse bilateral opacities on chest CT; and (3) DAD in histopathology [25, 26]. We acquired CT images of the lungs using a 16-slice CT scanner (BrightSpeed Elite SD, GE Healthcare, Chicago, IL, USA), with a scanning range from the apex to diaphragm. Images were acquired with following protocol: 120-kVp, 300-mAs, collimation width 16 × 1.25 mm, pitch factor 1.375, field of view 300 × 300 mm, rack rotation time 1.0 s/r, slice width 1.25 mm, and no intervals, reconstructed with a chest. All images were observed with optimized settings for lung evaluation (window width, 1500 HU; window level, −600HU) and analyzed by a veterinary radiologist. We assumed − 100 Uh above as nonaerated lung tissue and the region below − 100 HU as aerated lung tissue in three-dimension (3D) CT analysis .
For all animals, the veterinary pathologist examined the post-mortem lung tissue for identifying the key features of DAD. Tissues were harvested at 420 min after starting injection of saline or LPS. Lung tissue slices (3 μm thickness) were obtained and stained with hematoxylin and eosin (HE) for histological evaluation. In addition, immunohistochemical staining using anti-pan cytokeratin antibody (AE1/AE3) was performed for visualization of alveolar epithelial cells.
Values are expressed as mean ± standard deviation. We performed a two-sample t-test or Mann-Whitney U test to compare two independent groups, as appropriate. The one-way analysis of variance (ANOVA) followed by Sidak’s correction for post-hoc comparisons was performed for post-hoc comparisons. We examined the TPTD and laboratory data using a mixed-effects model for repeated-measures analyses, followed by ANOVA with Sidak’s correction for post hoc comparisons. Spearman’s correlation coefficients (r) were calculated to evaluate the correlation between each parameter. To examine the accuracy of the ELWI and PVPI for detecting acute lung injury, we performed receiver operating characteristic (ROC) curve analyses. We compared the area under the ROC curve (AUCs) between two pairs of potential predictors by a non-parametric test . A two-sided P < 0.05 was considered statistically significant. All statistical analyses were performed using the GraphPad Prism, version 8.3.0 (GraphPad Software, San Diego, CA).
Changes in TPTD parameters, lung physiology, and serum inflammatory mediators in sepsis-induced ARDS
We assessed the hemodynamics changes and lung physiology in the sepsis-induced ARDS model. The 4-h survival rate was 100% in the control group, while 28.6% in ARDS groups (log-rank P = 0.012). Changes overtime in all hemodynamic parameters in the ARDS group significantly differed from those in the control group (mixed-effect model, P < 0.0001 for all) (Fig. 2 and Additional file 1: Figure S1). Animals in the acute lung injury group reached markedly lower P/F, MAP, ScvO2, SVR, and higher PVPI, higher heart rate, lactate, PPV within 90 min than those in the control group (Fig. 2). Regarding CT imaging, animals in the ARDS group presented an extent of consolidation in bilateral gravitationally dependent gradient that expands over time, with diffuse ground-glass opacification (Fig. 3A). In the 3D-CT analysis, aerated lung volume decreased from 100% of the baseline volume to 84.5%, 71.4%, 63.1%, and 57.1% at 60, 120, 180, and 240 min, respectively (Fig. 3A). For lung histological and immunohistochemical findings, dilation of alveolar capillaries with congestion, infiltration of inflammatory cells mainly composed of neutrophil and macrophage infiltrates in alveoli, leakage of eosinophilic proteinaceous materials and precipitation of fibrin in the alveolar space, as well as shedding of alveolar epithelial cells positive for anti-pan cytokeratin antibody in the alveoli were conspicuous in the ARDS groups, but not in the control group (Fig. 3B). Figure 3C represents gross pulmonary findings at the end of experiment in animals subjected to LPS injection. Gross lung sections in the ARDS group show severe pulmonary hemorrhage and edema. These findings indicate that our model recapitulated the physiologic, radiographic, and histopathologic features of human ARDS.
PVPI and ELWI assessments in the ARDS during septic shock
PVPI and ELWI in the ARDS group increased over time (Fig. 4A). We identified a positive linear trend between the PVPI and the severity of ARDS (ANOVA for trend, P < 0.0001), with the highest (6.2 ± 0.3) and lowest (3.2 ± 0.0) PVPI values in the severe ARDS and normal statuses, respectively (Fig. 4B). Moreover, the ELWI increased significantly with the severity of ARDS (P < 0.0001) (Fig. 4B).
We plotted ROC curves to determine the values of the PVPI and ELWI for predicting the ARDS severity (Fig. 5A). AUCs of the PVPI and ELWI were 0.99 (95% CI 0.98–1.00; P < 0.0001) and 0.93 (0.88–0.98; P < 0.0001), respectively, for predicting the development of ARDS. The PVPI cut-off of 3.9 provided the optimal sensitivity and specificity (sensitivity = 100%, specificity = 92.5%). We also identified the ELWI cut-off of 11.8 mL/kg as the optimal value (sensitivity = 87.5%, specificity = 89.2%). The AUC for PVPI was significantly superior to that for ELWI, with respect to ARDS diagnosis (P < 0.01, Fig. 5C). In animals showing ARDS (P/F < 300), AUCs of the PVPI and ELWI were 0.76 (0.58–0.94; P = 0.01; optimal cut-off, 5.1) and 0.83 (0.67–1.00; P < 0.001; optimal cut-off, 13.6), respectively, for distinguishing between mild to moderate (100 ≤ P/F < 300) and severe ARDS (P/F < 100). Figure 6 presents the plots for all animals according to the severity of ARDS
Serial changes in inflammatory cytokine, HMGB1, and hematocrit levels and platelet counts during the experiment are presented in Additional file 1: Figure S2. For all markers, there were significant differences in serial changes over time between the control and ARDS groups (mixed-effect model, P < 0.0001 for all, except IFN-α [P = 0.043]) ( Additional file 1: Figure S2. To further investigate the role of PVPI in the development of ARDS, we analyzed its association with serum inflammatory mediators and P/F. Animals with PVPI > 3.9 displayed significant positive correlations between the PVPI and IL-1β, IL-6, and HMGB1 (r = 0.54, P < 0.001; r = 0.53, P = 0.001; r = 0.62, P < 0.001, respectively) and negative correlations between the PVPI and P/F (r = −0.44, P = 0.008) (Fig. 7). Animals with ELWI > 11.8 displayed significant positive correlations between the ELWI and IL-1β, IL-6, and HMGB1 (r = 0.53, P < 0.001; r = 0.37, P = 0.02; r = 0.58, P < 0.001, respectively) and negative correlations between the ELWI and P/F (r = −0.51, P = 0.001) (Fig. 8). Additional file 1: Figure S3 and S4 depicts the relationships of the PVPI and ELWI with other inflammatory makers.
This study provides clear evidence that both PVPI and ELWI significantly increased with the severity of ARDS related to LPS-induced septic shock. PVPI has shown to be superior to ELWI when considering their diagnostic properties regarding ARDS. In this pig model, the PVPI cut-off of 3.9 provided optimal sensitivity and specificity for distinguishing ARDS from a normal lung status (AUC, 0.99; 95% CI 0.98–1.00; P < 0.0001; sensitivity = 100%, specificity = 92.5%). Furthermore, the PVPI was significantly correlated with increased serum inflammatory mediators and worsened oxygenation in animals developing ARDS. These novel findings are essential for the management of patients with septic ARDS and support the hypothesis that the PVPI can be a reliable indicator of ARDS severity during septic shock.
The most important findings in the current study are that PVPI is well associated with multiple parameters that reflect clinicopathological changes in animals with ARDS. To the best of our knowledge, human or animal research has been very limited so far in verifying the validity of TPTD measurements to assess extravascular lung water and pulmonary vascular permeability during septic shock-induced ARDS. Importantly, an early diagnosis and assessment of ARDS severity will largely improve the outcome in patients with ARDS [29, 30]. Our findings are therefore crucial because no direct or highly reproducible approach assessing pulmonary vascular permeability exists in the current therapeutic strategy for patients with ARDS.
Currently, the “Berlin definition” does not include the ELWI or PVPI [25, 31] owing to concerns over arbitrary cut-off values, methodological concerns, and limited availability worldwide . However, several experts have proposed objective diagnoses for ARDS using ELWI and PVPI [11, 12] and the inclusion of both parameters in a future definition [33, 34]. We observed a significant increase in the PVPI along with worsened oxygenation during septic ARDS, consistent with previous reports [14, 18, 35]. Based on the results from large clinical studies on TPTD techniques in ARDS [14, 18, 36, 37], critical care experts have proposed that a PVPI < 2 may represent normal pulmonary permeability, whereas that > 3 indicates leaky lungs . By contrast, the cut-off value for ARDS obtained in the current study was higher than that in previous human studies. This discrepancy could be explained by the difference in species. Further studies are required to understand the noticeable differences between human ARDS and pig model of acute lung injury in terms of PVPI value in several conditions.
Based on evidence from pathological and clinical studies [15, 37,38,39], a normal ELWI does not exceed 10 ml/kg and one > 10 mL/kg is a reasonable threshold for pulmonary edema. An increase in ELWI > 15 mL/kg identified patients with DAD with 99% certainty ; therefore, researchers have proposed an ELWI > 15 mL/kg to indicate severe pulmonary edema . Our current study demonstrated similar results that the ELWI was 10.5 ± 0.2 mL/kg in animals with normal lung, compared with 15.3 ± 0.5 mL/kg in those with severe ARDS, thus highlighting the accuracy of the TPTD-based ELWI measurement.
Interestingly, the absence of adequate preclinical animal models to study the syndrome is a major barrier to improved ARDS diagnosis and management . No single animal model satisfactorily reproduces all histopathological elements of ARDS . In the current study, we used the novel septic-ARDS model and confirmed that the LPS “two-hit” infusions could reproductively induce DAD, systemic inflammation, distributive shock, and clinically relevant physiological characteristic of sepsis. LPS or endotoxin induced-ARDS pig model is relatively reproducible  and has clinical relevance in terms of the etiology , direct damages to and subsequent apoptosis of the endothelial cells by endotoxin [42, 44], and the activation of a systemic inflammatory response . Furthermore, a recent international consensus by a multidisciplinary working group from the National Heart, Lung, and Blood Institute has recommended the use of large animal models of ARDS rather rodent models, owing to their genetic and physiological similarities with human and greater potential for clinical translation . Recently, Tiba et al. introduced a novel swine model of ARDS in which combination of indirect (injection of Escherichia coli into the kidney) and direct lung injuries (volutrauma, hyperoxia, and bronchoscope-delivered gastric particles) faithfully recapitulated the physiologic, radiographic, and histopathologic features of human ARDS . By contrast, we used only LPS infusions to easily reproduce the clinically relevant features of human ARDS. It likely fills a crucial gap in the translational study of clinical ARDS.
Our study had some limitations that should be addressed in the future. First, the sample size was small and could have resulted in a type 1 error, thus warranting further studies to confirm our findings. Second, we only included female animals to minimize heterogeneity. Females are more likely than males to develop ARDS ; therefore, future studies should include both males and females to understand the association between acute lung injury and the sex hormones. Third, the current study did neither obtain data regarding long-term changes in ELWI or PVPI nor proposed an explanation for the pathophysiological mechanisms underlying ARDS and changes in associated parameters. For example, the association between prone positioning and PVPI values during ARDS was not investigated. Eventually, the animals in our model were ventilated without PEEP to easily induce atelectrauma, which could have affected our results. ARDS severity was determined by P/F; however, PEEP could have affected the P/F . Finally, it is considered that it is still early to apply this cut-off value to human in clinical. Similar to previously study, in our experiments, the baseline value of PVPI in pigs may be higher than in human .
In conclusion, the current study demonstrated that PVPI is a valid indicator to quantify the LPS-induced septic ARDS severity. The usefulness of PVPI value to diagnose and manage ARDS during septic shock should be acknowledged by clinicians. This is a novel and important finding that supports additional translational research for the management of septic ARDS. Further evaluations are required in clinical settings to continue assessing its usefulness and ability for improving the outcomes in patients with septic ARDS.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA. 2018;319(7):698–710.
Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, et al. Epidemiology, patterns of Care, and mortality for patients with Acute Respiratory Distress Syndrome in Intensive Care Units in 50 countries. JAMA. 2016;315(8):788–800.
Needham DM, Yang T, Dinglas VD, Mendez-Tellez PA, Shanholtz C, Sevransky JE, Brower RG, Pronovost PJ, Colantuoni E. Timing of low tidal volume ventilation and intensive care unit mortality in acute respiratory distress syndrome. A prospective cohort study. Am J Respir Crit Care Med. 2015;191(2):177–85.
Frohlich S, Murphy N, Doolan A, Ryan O, Boylan J. Acute respiratory distress syndrome: underrecognition by clinicians. J Crit Care. 2013;28(5):663–8.
Villar J, Perez-Mendez L, Kacmarek RM. The Berlin definition met our needs: no. Intensive Care Med. 2016;42(5):648–50.
Villar J, Blanco J, del Campo R, Andaluz-Ojeda D, Diaz-Dominguez FJ, Muriel A, Corcoles V, Suarez-Sipmann F, Tarancon C, Gonzalez-Higueras E, et al. Assessment of PaO(2)/FiO(2) for stratification of patients with moderate and severe acute respiratory distress syndrome. BMJ Open. 2015;5(3):e006812.
Thille AW, Esteban A, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Penuelas O, Cortes-Puch I, Cardinal-Fernandez P, Lorente JA, Frutos-Vivar F. Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med. 2013;187(7):761–7.
Monnet X, Shi R, Teboul JL. Prediction of fluid responsiveness. What’s new? Ann Intensive Care. 2022;12(1):46.
Rass V, Bogossian EG, Ianosi BA, Peluso L, Kofler M, Lindner A, Schiefecker AJ, Putnina L, Gaasch M, Hackl WO, et al. The effect of the volemic and cardiac status on brain oxygenation in patients with subarachnoid hemorrhage: a bi-center cohort study. Ann Intensive Care. 2021;11(1):176.
Malbrain M, Langer T, Annane D, Gattinoni L, Elbers P, Hahn RG, De Laet I, Minini A, Wong A, Ince C, et al. Intravenous fluid therapy in the perioperative and critical care setting: executive summary of the International Fluid Academy (IFA). Ann Intensive Care. 2020;10(1):64.
Jozwiak M, Teboul JL, Monnet X. Extravascular lung water in critical care: recent advances and clinical applications. Ann Intensive Care. 2015;5(1):38.
Tagami T, Ong MEH. Extravascular lung water measurements in acute respiratory distress syndrome: why, how, and when? Curr Opin Crit Care. 2018;24(3):209–15.
Monnet X, Teboul JL. Transpulmonary thermodilution: advantages and limits. Crit Care. 2017;21(1):147.
Kushimoto S, Taira Y, Kitazawa Y, Okuchi K, Sakamoto T, Ishikura H, Endo T, Yamanouchi S, Tagami T, Yamaguchi J, et al. The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective multicenter study on the quantitative differential diagnostic definition for acute lung injury/acute respiratory distress syndrome. Crit Care. 2012;16(6):R232.
Tagami T, Sawabe M, Kushimoto S, Marik PE, Mieno MN, Kawaguchi T, Kusakabe T, Tosa R, Yokota H, Fukuda Y. Quantitative diagnosis of diffuse alveolar damage using extravascular lung water. Crit Care Med. 2013;41(9):2144–50.
Sakka SG, Klein M, Reinhart K, Meier-Hellmann A. Prognostic value of extravascular lung water in critically ill patients. Chest. 2002;122(6):2080–6.
Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, Teboul JL, Monnet X. Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med. 2013;41(2):472–80.
Monnet X, Anguel N, Osman D, Hamzaoui O, Richard C, Teboul JL. Assessing pulmonary permeability by transpulmonary thermodilution allows differentiation of hydrostatic pulmonary edema from ALI/ARDS. Intensive Care Med. 2007;33(3):448–53.
Gavelli F, Shi R, Teboul JL, Azzolina D, Mercado P, Jozwiak M, Chew MS, Huber W, Kirov MY, Kuzkov VV, et al. Extravascular lung water levels are associated with mortality: a systematic review and meta-analysis. Crit Care. 2022;26(1):202.
Loosen G, Conrad AM, Hagman M, Essert N, Thiel M, Luecke T, Krebs J. Transpulmonary thermodilution in patients treated with veno-venous extracorporeal membrane oxygenation. Ann Intensive Care. 2021;11(1):101.
Chew MS, Ihrman L, During J, Bergenzaun L, Ersson A, Unden J, Ryden J, Akerman E, Larsson M. Extravascular lung water index improves the diagnostic accuracy of lung injury in patients with shock. Crit Care. 2012;16(1):R1.
Endo Y, Hirokawa T, Miyasho T, Takegawa R, Shinozaki K, Rolston DM, Becker LB, Hayashida K. Monitoring the tissue perfusion during hemorrhagic shock and resuscitation: tissue-to-arterial carbon dioxide partial pressure gradient in a pig model. J Transl Med. 2021;19(1):390.
Lemson J, Merkus P, van der Hoeven JG. Extravascular lung water index and global end-diastolic volume index should be corrected in children. J Crit Care. 2011;26(4):432 e437-412.
Langin M, Konrad M, Reichart B, Mayr T, Vandewiele S, Postrach J, Mokelke M, Radan J, Brenner P, Bauer A, et al. Hemodynamic evaluation of anesthetized baboons and piglets by transpulmonary thermodilution: normal values and interspecies differences with respect to xenotransplantation. Xenotransplantation. 2020;27(5):e12576.
Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–33.
Tiba MH, McCracken BM, Leander DC, Colmenero CI, Nemzek JA, Sjoding MW, Konopka KE, Flott TL, VanEpps JS, Daniels RC, et al. A novel swine model of the acute respiratory distress syndrome using clinically relevant injury exposures. Physiol Rep. 2021;9(9):e14871.
Cornejo RA, Diaz JC, Tobar EA, Bruhn AR, Ramos CA, Gonzalez RA, Repetto CA, Romero CM, Galvez LR, Llanos O, et al. Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2013;188(4):440–8.
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.
Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2003;167(7):1027–35.
Yadav H, Thompson BT, Gajic O. Fifty years of research in ARDS. Is acute respiratory distress syndrome a preventable disease? Am J Respir Crit Care Med. 2017;195(6):725–36.
Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573–82.
Camporota L, De Neef M, Beale R. Extravascular lung water in acute respiratory distress syndrome: potential clinical value, assumptions and limitations. Crit Care. 2012;16(1):114.
Perel A. Extravascular lung water and the pulmonary vascular permeability index may improve the definition of ARDS. Crit Care. 2013;17(1):108.
Phillips CR. The Berlin definition: real change or the emperor’s new clothes? Crit Care. 2013;17(4):174.
Groeneveld AB, Verheij J. Extravascular lung water to blood volume ratios as measures of permeability in sepsis-induced ALI/ARDS. Intensive Care Med. 2006;32(9):1315–21.
Tagami T, Kushimoto S, Tosa R, Omura M, Yonezawa K, Akiyama G, Hirama H, Yokota H. Plasma neutrophil elastase correlates with pulmonary vascular permeability: a prospective observational study in patients with pneumonia. Respirology. 2011;16(6):953–8.
Tagami T, Kushimoto S, Yamamoto Y, Atsumi T, Tosa R, Matsuda K, Oyama R, Kawaguchi T, Masuno T, Hirama H, et al. Validation of extravascular lung water measurement by single transpulmonary thermodilution: human autopsy study. Crit Care. 2010;14(5):R162.
Eichhorn V, Goepfert MS, Eulenburg C, Malbrain ML, Reuter DA. Comparison of values in critically ill patients for global end-diastolic volume and extravascular lung water measured by transcardiopulmonary thermodilution: a meta-analysis of the literature. Med Intensiva. 2012;36(7):467–74.
Wolf S, Riess A, Landscheidt JF, Lumenta CB, Schurer L, Friederich P. How to perform indexing of extravascular lung water: a validation study. Crit Care Med. 2013;41(4):990–8.
Semler MW, Bernard GR, Aaron SD, Angus DC, Biros MH, Brower RG, Calfee CS, Colantuoni EA, Ferguson ND, Gong MN, et al. Identifying clinical research priorities in adult pulmonary and critical care: NHLBI working group report. Am J Respir Crit Care Med. 2020. https://doi.org/10.1164/rccm.201908-1595WS.
Matthay GM-BaMA. Animal models of acute lung injury. American Thoracic Society. 2022. https://www.thoracic.org/professionals/clinical-resources/critical-care/critical-care-research/animal-models-of-acute-lung-injury.php. Accessed on 03 Feb 2022.
Wiener-Kronish JP, Albertine KH, Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest. 1991;88(3):864–75.
Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685–93.
Wang HL, Akinci IO, Baker CM, Urich D, Bellmeyer A, Jain M, Chandel NS, Mutlu GM, Budinger GR. The intrinsic apoptotic pathway is required for lipopolysaccharide-induced lung endothelial cell death. J Immunol. 2007;179(3):1834–41.
Monick MM, Hunninghake GW. Activation of second messenger pathways in alveolar macrophages by endotoxin. Eur Respir J. 2002;20(1):210–22.
Heffernan DS, Dossett LA, Lightfoot MA, Fremont RD, Ware LB, Sawyer RG, May AK. Gender and acute respiratory distress syndrome in critically injured adults: a prospective study. J Trauma. 2011;71(4):878–83. discussion 883 – 875.
Estenssoro E, Dubin A, Laffaire E, Canales HS, Saenz G, Moseinco M, Bachetti P. Impact of positive end-expiratory pressure on the definition of acute respiratory distress syndrome. Intensive Care Med. 2003;29(11):1936–42.
Xu X, Jia C, Luo S, Li Y, Xiao F, Dai H, Wang C. Effect of HA330 resin-directed hemoadsorption on a porcine acute respiratory distress syndrome model. Ann Intensive Care. 2017;7(1):84.
This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI Grant Number JP15K15112 and 21K16596) and internal funding.
Ethics approval and consent to participate
Consent for publication
Dr. Tagami is member of the Medical Advisory Board of Pulsion Medical Systems, Getinge. Other authors have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file 1:
Figure S1. Changes in hemodynamic parameters (mixed-effect model, P < 0.0001 for all). n=6 for the control group, n=7 for ARDS group. * P < 0.05, ** P < 0.01, ‡ P < 0.001, and § P < 0.0001 between each group. SV, stroke volume; GEF, global ejection fraction; GEDI, global end-diastolic volume index; and SVV, stroke volume variation. Figure S2. Changes in inflammatory markers, hematocrit, and platelet counts during the experiment (mixed-effect model, P < 0.0001 for all). n=6 for the control group, n=7 for ARDS group. * P < 0.05, ** P < 0.01, ‡ P < 0.001, and § P < 0.0001 between each group. Figure S3. Correlations between the pulmonary vascular permeability index (PVPI) and experimental parameters in a subgroup of animals with PVPI >3.9. Figure S4. Correlations between extravascular lung water index (ELWI) and experimental parameters in a subgroup of animals with ELWI > 11.8.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Endo, Y., Miyasho, T., Endo, K. et al. Diagnostic value of transpulmonary thermodilution measurements for acute respiratory distress syndrome in a pig model of septic shock. J Transl Med 20, 617 (2022). https://doi.org/10.1186/s12967-022-03793-x
- Pulmonary vascular permeability index
- Extravascular lung water
- Diagnostic criteria
- Large animal study